The page is the record's research on the issuer — no analyst, no rating, no view.

# Oncopeptides AB (Nasdaq Stockholm: SE0009414576) — research page

As of 2026-11-11 · se-cm-kg · record version 1

## Identity and listing

Oncopeptides AB is listed on Nasdaq Stockholm under ticker SE0009414576, with ISIN SE0009414576 and LEI 549300J9WWQ5CBYQ1M77. The security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.

## The disclosure read

The record holds 44 filings in the twelve months to 2026-11-11, across 40 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-11-09, two days before the record date, and is of type Inside information. On Nasdaq Stockholm the record holds 398 issuers, with a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days; the issuer's filing count is above the exchange median and its cadence gap and latency are below it. The sector median is not on the record.

## Auditor

The auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.

## Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed and not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.

## Coverage

The issuer's investor-relations page names 3 research houses: ABG Sundal Collier, DNB Carnegie and Redeye.

## Open research

No openly published research notes were found for the issuer.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed, and no years for the issuer are sealed. The market's earliest sealed date and the live record start date are not on the record.

## Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://firds.esma.europa.eu/firds/ (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.se-cm-kg.ai/events/XSTO/SE0009414576 (the disclosure lines)
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- https://oncopeptides.com/investors/the-share/ (coverage)
- https://mcp.se-cm-kg.ai/record/XSTO/SE0009414576 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/se/XSTO/SE0009414576 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp